Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH...

Area of Science:

• Genomics and Bioinformatics
• Hematologic Malignancies
• Molecular Diagnostics

Background:

• Fluorescence in situ hybridization (FISH) is standard for copy-number aberration (CNA) detection in chronic lymphocytic leukemia (CLL).
• Illumina BeadChips, designed for methylation screening, offer potential for extrapolating CNA data from existing diagnostic samples.
• Assessing the utility of microarray data for CNA diagnostics is increasingly relevant due to data availability.

Purpose of the Study:

• To benchmark the accuracy of CNA detection from Illumina EPIC and 450k BeadChips using conumee and ChAMP packages.
• To compare microarray-based CNA detection with FISH-based assessment for specific deletions (11q, 13q, 17p) in CLL.
• To evaluate the need for tailored bioinformatics analysis for different CNAs.

Main Methods:

• Analysis of 202 CLL samples using Illumina EPIC and 450k microarrays.
• Application of conumee and ChAMP bioinformatics packages for CNA prediction.
• Comparison of CNA predictions with established FISH-based diagnostic results for 11q, 13q, and 17p deletions.

Main Results:

• Both conumee and ChAMP packages showed similar accuracy in predicting CNAs from microarray data, irrespective of the BeadChip type.
• Microarray-based CNA predictions demonstrated lower accuracy compared to FISH-based assessments.
• No universal bioinformatics settings were identified; analysis requires specific adjustments for each CNA.

Conclusions:

• While methylation microarray data can predict CNAs in CLL, the accuracy is limited.
• FISH-based assessment remains the superior diagnostic method for detecting critical deletions in CLL.
• Further optimization of bioinformatics pipelines is necessary to improve CNA detection from microarray data.